FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer
Interventions: RADIATION: fludeoxyglucose F 18|DEVICE: positron emission tomography|DEVICE: dynamic contrast-enhanced magnetic resonance imaging|OTHER: laboratory biomarker analysis
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)